THERAMETRICS
Table of contents:
The "THERAMETRICS" trademark, serial number 75933378 , was filed on 2nd of March 2000 with a mark drawing code of 1000 and its transaction date is 75933378. Since 24th of September 2012, the document can be found in the M70 law office in the publication and issue section. The employee responsible is THOMPSON, LAVERNE and the date it was published for opposition on 10/24/2000. The status of the trademark was checked last on 09/21/2012.
The "THERAMETRICS" trademark, serial number 79143473 , was filed on 22nd of November 2013 with a mark drawing code of 4000 and its transaction date is 79143473. The attorney assigned is Steven A. Abreu, attorney docket number 4065A/2001. Since 10th of June 2014, the document can be found in the L70 law office in the publication and issue section. The date when we last checked the status of this trademark was 06/10/2014.
The corresponded responsible for this trademark is Steven A. Abreu, located at Sunstein Kann Murphy & Timbers LLP, 125 Summer Street, Boston MA 02110.The state or country where the trademark was organized is by Therametrics Holding Ag. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Mürgstrasse 18; Ch-6370 Stans, , zip .
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 03/07/2014 |
| Primary Code | 005 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 03/07/2014 |
| Primary Code | 042 |
| Goods codes | |
| GS0051 | Pharmaceutical, and medicinal products and preparations for the treatment of cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical preparations for sanitary purposes for medicine; pharmaceutical products for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, scleroderma, lupus erythematosus associated pulmonary hypertension, congenital systemic-to-pulmonary shunts associated pulmonary hypertension, portal hypertension associated pulmonary hypertension, HIV infection associated pulmonary hypertension, drugs and toxins associated pulmonary hypertension, glycogen storage disease associated pulmonary hypertension, Gaucher disease associated pulmonary hypertension, hereditary hemorrhagic telangiectasia associated pulmonary hypertension, hemoglobinopathies associated pulmonary hypertension, myeloproliferative disorders associated pulmonary hypertension, pulmonary veno-occlusive disease associated pulmonary hypertension, pulmonary capillary hemangiomatosis associated pulmonary hypertension, persistent pulmonary hypertension of the newborn, left-sided atrial or ventricular heart disease associated pulmonary hypertension, left-sided valvular heart disease associated pulmonary hypertension, pulmonary hypertension associated with chronic obstructive pulmonary disease, pulmonary hypertension associated with interstitial lung diseases, pulmonary hypertension associated with sleep disordered-breathing, pulmonary hypertension associated with alveolar hypoventilation disorders, pulmonary hypertension associated with chronic exposure to high altitude, pulmonary hypertension associated with developmental abnormalities, pulmonary hypertension due to chronic thrombotic and embolic diseases, pulmonary embolism due to tumor, parasites, foreign material, pulmonary hypertension associated with in situ thrombosis, pulmonary hypertension associated with sarcoidosis, pulmonary hypertension associated with histiocytosis X, pulmonary hypertension associated with lymphangiomatosis, pulmonary hypertension associated with sickle-cell disease, Eisenmenger syndrome, chronic fatigue syndrome, bronchial asthma, rheumatoid arthritis, lupus, Goodpasture's syndrome, Wegener's granulomatosis, type 1 diabetes mellitus, Hashimoto's thyroiditis, Grave's disease, multiple sclerosis, Guillain-Barre syndrome, Addison's disease, acute disseminated encephalomyelitis, antiphospholipid antibody syndrome, aplastic anemia, myasthenia gravis, opsoclonus myoclonus syndrome, optic neuritis, Ord's thyroiditis, acute respiratory distress syndrome, acute lung injury, Hamman-Rich syndrome, idiopathic pulmonary fibrosis, bronchiolitis obliterans, hypersensitivity pneumonitis, lymphangiomyomatosis (LAM), usual interstitial pneumonia (UIP), Von Gierke syndrome, Osler-Weber-Rendu-Syndrome, small cell lung carcinoma, cystic fibrosis, tuberculosis, Hepatitis B virus infections, psoriasis, allergic dermatitis, scar keloids, pyogenic granulomas, blistering disease, Kaposi sarcoma in AIDS patients, systemic sclerosis, persistent hyperplastic vitreous syndrome, diabetic retinopathy, retinopathy of prematurity, choroidal neovascularization, inflammatory bowel disease, periodontal disease, ascites, peritoneal adhesions, endometriosis, uterine bleeding, ovarian cysts, ovarian hyperstimulation, osteomyelitis, osteophyte formation, HIV-induced bone marrow angiogenesis, early diabetic nephropathy, cancer and malignancies and their matastases in numerous organs, hemangiomas, vasculitis, Sjögren's disease, DiGeorge syndrome, hereditary haemorrhagic telangiectasia, cavernous hemangioma, cutaneous hemangioma, lymphatic malformations, transplant arteriopathy, vascular anastomoses, adipose tissue in obesity, chronic allograft rejections; chemical preparations intended for healing, health care or medical and veterinary purposes, namely, chemical preparations for treating inflammatory, cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; radiological contrast substances for medical purposes; detergents for medical purposes; medicated mouth care and treatment preparations; medicated skin care preparations |
| GS0421 | Scientific research to order; conducting of research and development in the medical, pharmaceutical, pharmacological, biochemical and/or medical technology fields for others; conducting to order clinical studies and tests, namely, conducting clinical trials for others; assessment to order of scientific projects, namely, conducting scientific feasibility studies; scientific research consulting in the nature of evaluation to order of clinical studies and experiments; providing technical advice relating to operation of computers; providing scientific cooperations in the nature of providing scientific information in the field of pharmaceutical research; conducting scientific research projects in the medical, pharmaceutical, pharmacological, biochemical, and/or medical technology fields for others; scientific analysis laboratories |
| INTERNATIONAL REGISTRATION | |
| International Registration Number | 1194259 |
|---|---|
| International Registration Date | 11/22/2013 |
| International Publication Date | 03/06/2014 |
| International Renewal Date | 11/22/2023 |
| Auto protection | 09/06/2015 |
| International Status Code | 001 - Request for extension of protection established |
| International Status Date | 03/06/2014 |
| Priority Claimed In | Yes |
| Priority Claimed Date | 06/13/2013 |
| First Refusal In | Yes |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 06/10/2014 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 06/10/2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 06/05/2014 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 05/23/2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 04/04/2014 | REFUSAL PROCESSED BY IB | P | RFNT - REFUSAL PROCESSED BY IB | |
| 03/14/2014 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | P | RFCS - REFUSAL SENT TO IB | |
| 03/14/2014 | REFUSAL PROCESSED BY MPU | P | RFRR | |
| 03/14/2014 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | E | RFCR - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | |
| 03/13/2014 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 03/11/2014 | APPLICATION FILING RECEIPT MAILED | O - Outgoing Correspondence | MAFR | |
| 03/10/2014 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 03/07/2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 03/06/2014 | SN ASSIGNED FOR SECT 66A APPL FROM IB | M | REPR - SN ASSIGNED FOR SECT 66A APPL FROM IB | |
The "THERAMETRICS" trademark, serial number 79142915 , was filed on 22nd of November 2013 with a mark drawing code of 3000 and its transaction date is 79142915. The attorney assigned is Steven A. Abreu, attorney docket number 4065A/2002. Since 10th of June 2014, the document can be found in the L70 law office in the publication and issue section. The date when we last checked the status of this trademark was 06/10/2014.
The corresponded responsible for this trademark is Steven A. Abreu, located at Sunstein Kann Murphy & Timbers LLP, 125 Summer Street, Boston MA 02110.The state or country where the trademark was organized is by Therametrics Holding Ag. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Mürgstrasse 18; Ch-6370 Stans, , zip .
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 02/25/2014 |
| Primary Code | 005 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 02/25/2014 |
| Primary Code | 042 |
| Goods codes | |
| CC0000 | Color is not claimed as a feature of the mark. |
| DM0000 | The mark consists of the stylized term "THERAMetrics" with three parallel diagonal lines appearing in front of the letter "M" in "THERAMetrics". |
| GS0051 | Pharmaceutical, and medicinal products and preparations for the treatment of cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical preparations for sanitary purposes for medicine; pharmaceutical products for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, scleroderma, lupus erythematosus associated pulmonary hypertension, congenital systemic-to-pulmonary shunts associated pulmonary hypertension, portal hypertension associated pulmonary hypertension, HIV infection associated pulmonary hypertension, drugs and toxins associated pulmonary hypertension, glycogen storage disease associated pulmonary hypertension, Gaucher disease associated pulmonary hypertension, hereditary hemorrhagic telangiectasia associated pulmonary hypertension, hemoglobinopathies associated pulmonary hypertension, myeloproliferative disorders associated pulmonary hypertension, pulmonary veno-occlusive disease associated pulmonary hypertension, pulmonary capillary hemangiomatosis associated pulmonary hypertension, persistent pulmonary hypertension of the newborn, left-sided atrial or ventricular heart disease associated pulmonary hypertension, left-sided valvular heart disease associated pulmonary hypertension, pulmonary hypertension associated with chronic obstructive pulmonary disease, pulmonary hypertension associated with interstitial lung diseases, pulmonary hypertension associated with sleep disordered-breathing, pulmonary hypertension associated with alveolar hypoventilation disorders, pulmonary hypertension associated with chronic exposure to high altitude, pulmonary hypertension associated with developmental abnormalities, pulmonary hypertension due to chronic thrombotic and embolic diseases, pulmonary embolism due to tumor, parasites, foreign material, pulmonary hypertension associated with in situ thrombosis, pulmonary hypertension associated with sarcoidosis, pulmonary hypertension associated with histiocytosis X, pulmonary hypertension associated with lymphangiomatosis, pulmonary hypertension associated with sickle-cell disease, Eisenmenger syndrome, chronic fatigue syndrome, bronchial asthma, rheumatoid arthritis, lupus, Goodpasture's syndrome, Wegener's granulomatosis, type 1 diabetes mellitus, Hashimoto's thyroiditis, Grave's disease, multiple sclerosis, Guillain-Barre syndrome, Addison's disease, acute disseminated encephalomyelitis, antiphospholipid antibody syndrome, aplastic anemia, myasthenia gravis, opsoclonus myoclonus syndrome, optic neuritis, Ord's thyroiditis, acute respiratory distress syndrome, acute lung injury, Hamman-Rich syndrome, idiopathic pulmonary fibrosis, bronchiolitis obliterans, hypersensitivity pneumonitis, lymphangiomyomatosis (LAM), usual interstitial pneumonia (UIP), Von Gierke syndrome, Osler-Weber-Rendu-Syndrome, small cell lung carcinoma, cystic fibrosis, tuberculosis, Hepatitis B virus infections, psoriasis, allergic dermatitis, scar keloids, pyogenic granulomas, blistering disease, Kaposi sarcoma in AIDS patients, systemic sclerosis, persistent hyperplastic vitreous syndrome, diabetic retinopathy, retinopathy of prematurity, choroidal neovascularization, inflammatory bowel disease, periodontal disease, ascites, peritoneal adhesions, endometriosis, uterine bleeding, ovarian cysts, ovarian hyperstimulation, osteomyelitis, osteophyte formation, HIV-induced bone marrow angiogenesis, early diabetic nephropathy, cancer and malignancies and their matastases in numerous organs, hemangiomas, vasculitis, Sjögren's disease, DiGeorge syndrome, hereditary haemorrhagic telangiectasia, cavernous hemangioma, cutaneous hemangioma, lymphatic malformations, transplant arteriopathy, vascular anastomoses, adipose tissue in obesity, chronic allograft rejections; chemical preparations intended for healing, health care or medical and veterinary purposes, namely, chemical preparations for treating inflammatory, cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; radiological contrast substances for medical purposes; detergents for medical purposes; medicated mouth care and treatment preparations; medicated skin care preparations |
| GS0421 | Scientific research to order; conducting of research and development in the medical, pharmaceutical, pharmacological, biochemical and/or medical technology fields for others; conducting to order clinical studies and tests, namely, conducting clinical trials for others; assessment to order of scientific projects, namely, conducting scientific feasibility studies; scientific research consulting in the nature of evaluation to order of clinical studies and experiments; providing technical advice relating to operation of computers; providing scientific cooperations in the nature of providing scientific information in the field of pharmaceutical research; conducting scientific research projects in the medical, pharmaceutical, pharmacological, biochemical, and/or medical technology fields for others; scientific analysis laboratories |
| INTERNATIONAL REGISTRATION | |
| International Registration Number | 1193030 |
|---|---|
| International Registration Date | 11/22/2013 |
| International Publication Date | 02/20/2014 |
| International Renewal Date | 11/22/2023 |
| Auto protection | 08/20/2015 |
| International Status Code | 001 - Request for extension of protection established |
| International Status Date | 02/21/2014 |
| Priority Claimed In | Yes |
| Priority Claimed Date | 06/13/2013 |
| First Refusal In | Yes |
DESIGN SETUP
Bands, straight; Bars, straight; Lines, straight; Straight line(s), band(s) or bar(s) . Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal . Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal . Geometric figures forming letters, numerals or punctuation .| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 06/10/2014 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 06/10/2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 06/05/2014 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 05/23/2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 04/04/2014 | REFUSAL PROCESSED BY IB | P | RFNT - REFUSAL PROCESSED BY IB | |
| 03/14/2014 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | P | RFCS - REFUSAL SENT TO IB | |
| 03/14/2014 | REFUSAL PROCESSED BY MPU | P | RFRR | |
| 03/14/2014 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | E | RFCR - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | |
| 03/13/2014 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 03/10/2014 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 03/01/2014 | APPLICATION FILING RECEIPT MAILED | O - Outgoing Correspondence | MAFR | |
| 02/25/2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 02/21/2014 | SN ASSIGNED FOR SECT 66A APPL FROM IB | M | REPR - SN ASSIGNED FOR SECT 66A APPL FROM IB | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.